IBRN ETF

$33.79
Screen 3,400+ ETFsFind similar ETFs with lower fees

Returns Overview

1 Month
-1.41%
3 Months
+1.23%
6 Months
+28.62%
YTD
+1.01%
1 Year
+29.04%
3 Years
+8.83%

Risk Metrics (5-Year)

No risk data available for this ETF

Stress Test Scenarios

How would IBRN have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
🔒Upgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
🔒Upgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
🔒Upgrade to run

1 Month Performance

-1.41%

3 Months Performance

+1.23%

6 Months Performance

+28.62%

1 Year Performance

+29.04%

Benchmark & Peers

Benchmark
NYSE FactSet Global Neuro Biopharma and MedTech Index(NYFSNBMT)
This ETF (YTD)
+1.01%
Peer Avg (YTD)
+1.55%
vs Peers
-0.54%

IBRN ETF Performance

IBRN performance across multiple time periods: 1-month -1.41%, YTD 1.01%, 1-year 29.04%, 3-year 8.83%.

IBRN returns trail the peer average of 1.55% YTD. With an expense ratio of 0.47%, investors should weigh costs against performance when evaluating this ETF.

IBRN performance comparison shows side-by-side returns with another fund. IBRN alternatives are available in the ETF Screener.

Performance & Returns

Loading chart...

Performance Returns

PeriodTotal ReturnDate Range
1 Month-1.41%N/A
3 Months+1.23%N/A
6 Months+28.62%N/A
1 Year+29.04%N/A
3 Years+8.83%N/A

All returns shown are total returns, not annualized